Israeli Biotech company says it can revolutionize drug development

The Jerusalem Post ^ | 14 March 2022 | Debbie Mohnblatt

[zeestephen]

Developing a new drug and bringing it to market typically costs around $2.6 billion and takes about 12 years...In Tissue Dynamics' platform, a robot makes microfluidic models of human tissues...It can perform, by itself, safety assessments in the microtissues and identify the drug that works best and causes the least damage to human organs..."We can do it in 19,000 tissue samples at once. It is the equivalent of [testing on] 5,000 patients..."

[Mr Radical]

Developing a new drug and bringing it to market typically costs around $2.6 billion and takes about 12 years
unless, of course ...

[ptsal]

Self-testing, self-certified..... Do not tell Pfizer.

[neverevergiveup]

There are a ton of small start ups trying to do this, and they’ve been at it for a decade. At best they will be able to screen for the least toxic drug candidates in specific tissue types, which will then have to be tested in clinical trials. Could be very helpful, but not a surrogate for clinical testing.

[zeestephen]

Re: not a surrogate for clinical testing

The article only claims a 30%-50% improvement in drug development time.

I like the idea because it makes smaller drug companies more competitive.

The technology will also have an impact on re-purposing approved drugs, treatments for uncommon diseases, and identifying environmental toxins.